NASDAQ:MEDS TRxADE HEALTH (MEDS) Stock Price, News & Analysis → A lot of people are making this costly mistake (From WealthPress) (Ad) Free MEDS Stock Alerts $10.24 +0.69 (+7.23%) (As of 05:21 PM ET) Add Compare Share Share Today's Range$8.53▼$10.7450-Day Range$4.11▼$33.9052-Week Range$3.69▼$44.56Volume113,108 shsAverage Volume443,030 shsMarket Capitalization$12.39 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get TRxADE HEALTH alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About TRxADE HEALTH Stock (NASDAQ:MEDS)TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.Read More MEDS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MEDS Stock News HeadlinesMarch 12, 2024 | msn.comFAIR Meds Act could impact costs for prescriptionsMarch 12, 2024 | msn.comA massive cyberattack has some Arizona health providers reeling. Here's what we knowMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 11, 2024 | msn.comTexas health centers awarded over $19 million in grantsMarch 11, 2024 | msn.comLexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare moversMarch 6, 2024 | msn.comCrude Oil Rises Sharply; Foot Locker Shares PlungeMarch 6, 2024 | msn.comTRxADE Health Stock Skyrockets: Here's WhyMarch 6, 2024 | globenewswire.comTRxADE Health, Inc. Announces Special Cash DividendMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. February 20, 2024 | msn.comNew model identifies drugs that shouldn’t be taken togetherFebruary 20, 2024 | seekingalpha.comGCT, VHC and IPWR among mid-day moversFebruary 20, 2024 | msn.comTRxADE HEALTH Rises Over 140% - What's Going On?February 20, 2024 | msn.comWhy Is Trxade Health (MEDS) Stock Up 230% Today?February 20, 2024 | investorplace.comWhy Is Trxade Health (MEDS) Stock Up 230% Today?February 19, 2024 | msn.comThere are spurious drugs for cancer, hypertension, cholesterol, pediatric diseases…only lab tests can spot them’February 6, 2024 | msn.comIs this a scam? Prescription drugs cost 3 times more in the U.S. than in other wealthy countriesFebruary 2, 2024 | msn.comFractyl Health valued at $654.6 mln in tepid debutFebruary 1, 2024 | msn.comBill aimed at making overdose-reversal medications more accessible via vending machinesJanuary 31, 2024 | msn.comTexas Supreme Court hears challenge to transgender minor health care banJanuary 31, 2024 | msn.com10 Medications Linked to DementiaJanuary 26, 2024 | msn.comCombining Medications For Erectile Dysfunction and Chest Pain May Increase Risk of DeathJanuary 19, 2024 | msn.comMarine vet touts benefits of psychedelic-assisted PTSD drugs as FDA considers MDMA approvalJanuary 17, 2024 | finance.yahoo.comTrxade health, Inc files its 3Q 10QJanuary 15, 2024 | msn.comErectile dysfunction medications may increase risk of death when combined with common chest pain medicationJanuary 15, 2024 | msn.comErectile dysfunction medications may increase early death risk when combined with common chest pain drug, study findsJanuary 12, 2024 | msn.comBeware meds that could turn your memory to garbageJanuary 12, 2024 | yahoo.comMedications for Essential TremorSee More Headlines Receive MEDS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings1/16/2024Dividend Payable3/22/2024Ex-Dividend for 3/22 Dividend3/25/2024Today3/28/2024Next Earnings (Estimated)5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryN/A Current SymbolNASDAQ:MEDS CUSIPN/A CIK1382574 Webwww.trxade.com Phone(800) 261-0281Fax800-265-6932Employees33Year FoundedN/APrice Target and Rating Average Stock Price Target$0.00 High Stock Price Target$0.00 Low Stock Price Target$10,000,000.00 Potential Upside/Downside+174.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)($6.9388) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,470,000.00 Net Margins-78.18% Pretax Margin-43.63% Return on Equity-69.22% Return on Assets-23.52% Debt Debt-to-Equity RatioN/A Current Ratio0.61 Quick Ratio0.28 Sales & Book Value Annual Sales$11.45 million Price / Sales1.01 Cash FlowN/A Price / Cash FlowN/A Book Value$0.55 per share Price / Book17.36Miscellaneous Outstanding Shares1,210,000Free Float622,000Market Cap$11.56 million OptionableNot Optionable Beta1.90 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Surendra K. Ajjarapu (Age 53)Founder, Chairman, CEO & Secretary Comp: $354.23kMr. Prashant Patel (Age 50)Founder, President, COO, Interim Principal Financial & Accounting Officer and Director Comp: $147.04kDr. Ramesh KenchappaChief Scientific OfficerMr. David M. Saslow Esq.Inhouse CounselMr. Jariel MoralesExecutive Vice PresidentDr. Shafaat Pirani Pharm.D.Executive Vice President of Alliance Pharma Solutions, LLCMore ExecutivesKey CompetitorsCosmos HealthNASDAQ:COSMBIMINASDAQ:BIMIPredictive OncologyNASDAQ:POAIBioCardiaNASDAQ:BCDAGuardion Health SciencesNASDAQ:GHSIView All Competitors MEDS Stock Analysis - Frequently Asked Questions How have MEDS shares performed in 2024? TRxADE HEALTH's stock was trading at $5.20 at the beginning of the year. Since then, MEDS stock has increased by 100.0% and is now trading at $10.40. View the best growth stocks for 2024 here. Are investors shorting TRxADE HEALTH? TRxADE HEALTH saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 56,000 shares, an increase of 80.6% from the February 29th total of 31,000 shares. Based on an average trading volume of 414,100 shares, the short-interest ratio is presently 0.1 days. Approximately 6.6% of the shares of the company are sold short. View TRxADE HEALTH's Short Interest. When is TRxADE HEALTH's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024. View our MEDS earnings forecast. How were TRxADE HEALTH's earnings last quarter? TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings data on Tuesday, January, 16th. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $2.06 million for the quarter. TRxADE HEALTH had a negative net margin of 78.18% and a negative trailing twelve-month return on equity of 69.22%. How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH? TRxADE HEALTH declared a dividend on Wednesday, February 28th. Shareholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th. Read our dividend analysis for MEDS. When did TRxADE HEALTH's stock split? TRxADE HEALTH's stock reverse split on the morning of Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of TRxADE HEALTH own? Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN). How do I buy shares of TRxADE HEALTH? Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MEDS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TRxADE HEALTH, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.